City
Arlington EMS System
Drugs and doses38
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Bismuth Subsalicylate, Calcium Chloride, Cefepime9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 650 mg | PO | not captured | standing | pages 71, 76 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | pages 71, 76 |
| Other | adult | 1–2 tablet | not captured | not captured | standing | page 151 |
| Other | adult | 15 mg/kg (max 1000 mg) | IV | not captured | standing | page 78 |
| Other | adult | 325 mg | PO | not captured | standing | pages 149, 150 |
| Mild to moderate pain | adult | 1 g | IV | not captured | standing | pages 76, 78 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | pages 76, 78 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 12 mg | IV | not captured | standing | pages 56, 155 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 56, 155 |
| Narrow-complex tachycardia | adult | 12 mg | IV | not captured | standing | pages 56, 155 |
| Narrow-complex tachycardia | adult | 12 mg | IV | not captured | standing | page 56 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | pages 56, 155 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 56 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| COPD | adult | 2.5–5 mg | NEB | not captured | standing | page 37 |
| Other | adult | 2.5–5 mg | NEB | not captured | standing | page 66 |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 37, 72, 156 |
| Other | adult | 7.5 mg | NEB | not captured | standing | pages 37, 47 |
| Other | peds | 2.5–5 mg | NEB | not captured | standing | page 66 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | pages 37, 72, 156 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 150 mg | IV/IO | not captured | standing | pages 53, 157 |
| Atrial fibrillation with RVR | adult | 150 mg | IV/IO | not captured | standing | pages 53, 157 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 53 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 57 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 57 |
| Wide-complex tachycardia | adult | 300 mg | IV/IO | not captured | standing | pages 57, 61, 157 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 57, 61, 157 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 61, 157 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 61, 157 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 51, 158 |
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 51, 158 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 54, 159 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 54, 159 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | pages 81, 159 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | pages 81, 159 |
| Other | adult | 0.5 mg | IV/IO | not captured | standing | page 81 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 54 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 81 |
Bismuth Subsalicylate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 262 mg | PO | not captured | standing | page 151 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | pages 63, 81, 160 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 63, 81, 160 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 63, 160 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 63, 160 |
| Other | adult | 500 mg | IV/IO | not captured | standing | pages 81, 160 |
| Other | adult | 500 mg | IV/IO | not captured | standing | page 81 |
Cefepime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IM | not captured | standing | pages 79, 101 |
| Sepsis | adult | 2 g | IV/IM | not captured | standing | page 79 |
| Sepsis | adult | 2 g | IV/IO/IM | not captured | standing | page 79 |
D–F Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Fentanyl6
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 71, 163 |
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 63 |
| Hypoglycemia | adult | 250 mL | IV/IO | not captured | standing | pages 63, 71, 163 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | pages 71, 163 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | page 63 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 63, 71, 163 |
| Other | adult | 25 g | IV/IO/PO | not captured | standing | page 71 |
| Other | peds | 2 mL/kg | IV/IO/PO | not captured | standing | page 71 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 20 mg | IV/IO | not captured | standing | pages 53, 164 |
| Atrial fibrillation with RVR | adult | 20 mg | IV/IO | not captured | standing | pages 53, 164 |
| Narrow-complex tachycardia | adult | 20 mg | IV/IO | not captured | standing | pages 56, 164 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | pages 66, 165 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO/IM/PO | not captured | standing | pages 66, 165 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 66, 165 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | page 66 |
| Nausea / vomiting | adult | 25 mg | IV/IM | not captured | standing | page 74 |
| Other | adult | 25 mg | PO | not captured | standing | pages 149, 151 |
| Other | adult | 50 mg | PO | not captured | standing | page 66 |
| Other | adult | 50 mg | IV/IO/IM | not captured | standing | page 83 |
| Other | peds | 12.5 mg | PO | not captured | standing | page 66 |
| Other | peds | 25 mg | PO | not captured | standing | page 66 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV | not captured | standing | pages 74, 146, 166 |
| Other | adult | 2.5–5 mg | IV/IM | not captured | standing | pages 68, 146, 166 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | pages 37, 66, 167 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 37, 66, 167 |
| Bradycardia | peds | 0.1 mL/kg | IV/IO | not captured | standing | pages 54, 167 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 60, 61, 167 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 60, 61, 167 |
| Hypotension / shock | peds | 0.1 mL/kg | IV/IO | not captured | standing | pages 75, 167 |
| Other | adult | 0.1 mg | IV/IO | not captured | standing | pages 66, 167 |
| Other | adult | 1 mL | IV/IO | not captured | standing | page 54 |
| Other | adult | 1 mL | IV/IO | not captured | standing | page 66 |
| Other | adult | 1 mL | IV/IO | not captured | standing | page 75 |
| Other | peds | 0.1 mL/kg | IV/IO | not captured | standing | pages 66, 167 |
| Other | peds | 0.1 mL/kg | IV/IO | not captured | standing | page 66 |
| Other | peds | 1 mL | IV/IO | not captured | standing | page 75 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 41, 168 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 41, 168 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 51, 76, 168 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 76 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 51, 76, 168 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 76 |
G–L Glucagon, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Labetalol, Lidocaine7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 81 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 81 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 3, 71 |
| Other | adult | 1 mg | IM | not captured | standing | pages 3, 71 |
| Other | peds | 1 mg | IM | not captured | standing | pages 3, 71 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 94, 169 |
| Cyanide poisoning | peds | 100 mg/kg | IV/IO | not captured | standing | pages 94, 169 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 tablet | not captured | not captured | standing | page 151 |
| Other | adult | 200 mg | PO | not captured | standing | pages 149, 150 |
| Other | adult | 400 mg | PO | not captured | standing | pages 76, 150 |
| Other | peds | 10 mg/kg | PO | not captured | standing | pages 76, 150 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 37, 72 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 37, 72 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 37 |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 37, 47 |
| Other | peds | 0.5 mg | NEB | not captured | standing | pages 37, 47 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO/IN | not captured | standing | page 68 |
| Agitation | adult | 2 mg/kg | IM | not captured | standing | page 68 |
| Agitation | peds | 10 mg | IV/IO/IN | not captured | standing | page 68 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 77 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | adult | 2–4 mg/kg | IM | not captured | standing | page 77 |
| Other | peds | 0.3 mg | IV/IO/IM/IN | not captured | standing | page 53 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 77 |
| Other | peds | 10 mg | IV/IO/IM/IN | not captured | standing | page 68 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | peds | 2–4 mg/kg | IM | not captured | standing | page 77 |
| Severe pain | adult | 0.3 mg/kg | IV/IO/IM/IN | not captured | standing | page 76 |
| Severe pain | peds | 0.3 mg/kg | IV/IO/IM/IN | not captured | standing | page 76 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | page 80 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mL | not captured | not captured | standing | page 140 |
| Wide-complex tachycardia | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 61 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV/IO | not captured | standing | page 61 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 61 |
| VF / pulseless VT | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 61 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | page 61 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 61 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Naloxone, Nitroglycerin, Ondansetron, Oral Glucose, Oxymetazoline8
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | page 61 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 37 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 57, 61 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 86 |
| Other | adult | 4 g | IV/IO | not captured | standing | page 86 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | page 61 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | page 61 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM/PO | not captured | standing | page 66 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM/PO | not captured | standing | page 66 |
| Other | adult | 125 mg | IV/IM | not captured | standing | page 37 |
| Other | adult | 125 mg | IV/IO/IM | not captured | standing | page 66 |
| Other | adult | 125 mg | IV/IM/PO | not captured | standing | page 83 |
| Other | adult | 125 mg | IV/IO/IM | not captured | standing | page 37 |
| Other | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 37 |
| Other | peds | 2 mg/kg | IV/IM/PO | not captured | standing | page 66 |
| Other | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 37 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | peds | 2–5 mg | IV/IM | not captured | standing | page 68 |
| Other | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 53, 56, 57 |
| Other | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 53, 56, 57 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 41 |
| Other | adult | 5 mg | IV/IO/IM/IN | not captured | standing | page 77 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 41 |
| Other | adult | 5–10 mg | IV/IO/IM/IN | not captured | standing | page 68 |
| Other | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | page 67 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 77 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 53, 56, 57 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 41 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 77 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 53, 56, 57 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 56, 57 |
| Other | peds | 0.2 mg/kg | IN | not captured | standing | pages 53, 56, 57 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 77 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV/IO | not captured | standing | page 81 |
| Other | adult | 0.5 mg | IV/IO | not captured | standing | page 81 |
| Other | adult | 1 mg | IM/IN | not captured | standing | page 81 |
| Other | adult | 1 mg | IM/IN | not captured | standing | page 81 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 81 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 89 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 81 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 81 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 81 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | page 51 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM | not captured | standing | page 74 |
| Nausea / vomiting | peds | 2 mg | IV/IO/IM | not captured | standing | page 74 |
| Other | adult | 4 mg | PO | not captured | standing | page 74 |
| Other | adult | 4 mg | IV/IO/IM | not captured | standing | page 74 |
| Other | peds | 2 mg | IV/IO/IM | not captured | standing | page 74 |
| Other | peds | 4 mg | PO | not captured | standing | page 74 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 30 g | PO | not captured | standing | page 71 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 71 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 136 |
| Other | peds | 2 spray | IN | not captured | standing | page 136 |
P–R Plasma, Rocuronium2
Plasma
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 unit | IV/IO | not captured | standing | page 101 |
| Other | peds | 1 unit | IV/IO | not captured | standing | page 101 |
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 101 |
| Trauma / hemorrhage | peds | 1 unit | IV/IO | not captured | standing | page 101 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 41 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 41 |
S–Z Sodium Bicarbonate, Terbutaline, Tetracaine, Tranexamic Acid, Vecuronium, Whole Blood6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 63 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 63 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 63 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 92 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 92 |
| Other | adult | 50 mEq | IV | not captured | standing | page 70 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 63 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 92 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 81, 186 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 81, 186 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | pages 37, 184 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | page 188 |
| Other | adult | 2 drop | OPH | not captured | standing | page 92 |
| Other | peds | 2 drop | OPH | not captured | standing | page 92 |
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | pages 92, 188 |
| Mild to moderate pain | peds | 2 drop | OPH | not captured | standing | pages 92, 188 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2 g | IV | not captured | standing | page 83 |
| Other | adult | 1 g | IM | not captured | standing | page 152 |
| Other | adult | 2 g | IV | not captured | standing | page 83 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 152 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 152 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 88 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 101 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | page 101 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 88, 101, 152, 189 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | pages 88, 101, 152, 189 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 10 mg | IV/IO | not captured | standing | pages 41, 190 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 41, 190 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 101 |
| Trauma / hemorrhage | peds | 1 unit | IV/IO | not captured | standing | page 101 |
Cite this
Arlington EMS System, United States EMS Protocol Census. 219 dose entries, effective 2026-03-16.
https://protoquiz.com/census/agencies/arlington-ems-system/
The census is free and not for sale. Only public agencies are named.